JPMorgan Resumes Pfizer (PFE) at Overweight
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.29 +2.62%
Rating Summary:
15 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Rating Summary:
15 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Join SI Premium – FREE
JPMorgan resumed coverage on Pfizer (NYSE: PFE) with an Overweight rating and a price target of $38.00.
For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.
Shares of Pfizer closed at $32.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
- B.Riley Starts Nutex Health (NUTX) at Buy
- Nomura/Instinet Starts Star Health & Allied Insurance (STARHEAL:IN) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
